Latest Insider Transactions at Oscar Health, Inc. (OSCR)
This section provides a real-time view of insider transactions for Oscar Health, Inc. (OSCR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Oscar Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Oscar Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 05
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+15.82%
|
-
|
Sep 05
2022
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+15.86%
|
-
|
Sep 02
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
2,947
-2.14%
|
$14,735
$5.85 P/Share
|
Sep 02
2022
|
Dennis Weaver Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
1,596
-6.61%
|
$7,980
$5.85 P/Share
|
Sep 02
2022
|
Ranmali Bopitiya EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,167
-17.68%
|
$30,835
$5.85 P/Share
|
Sep 02
2022
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,207
-0.81%
|
$11,035
$5.85 P/Share
|
Sep 01
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,015
+4.84%
|
-
|
Sep 01
2022
|
Dennis Weaver Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,172
+11.91%
|
-
|
Sep 01
2022
|
Ranmali Bopitiya EVP & Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,425
+36.93%
|
-
|
Sep 01
2022
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,015
+2.52%
|
-
|
Sep 01
2022
|
Victoria Baltrus Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,363
+39.64%
|
-
|
Jun 09
2022
|
Jeffery H Boyd |
BUY
Grant, award, or other acquisition
|
Direct |
35,787
+29.44%
|
-
|
Jun 09
2022
|
Vanessa Ames Wittman |
BUY
Grant, award, or other acquisition
|
Direct |
35,787
+29.44%
|
-
|
Jun 09
2022
|
Jr Charles E Phillips |
BUY
Grant, award, or other acquisition
|
Direct |
35,787
+29.44%
|
-
|
Jun 09
2022
|
David Plouffe |
BUY
Grant, award, or other acquisition
|
Direct |
35,787
+29.44%
|
-
|
Jun 09
2022
|
Elbert O. Robinson Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
35,787
+29.44%
|
-
|
Jun 06
2022
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
19,546
-6.89%
|
$97,730
$5.01 P/Share
|
Jun 06
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
11,300
-7.94%
|
$56,500
$5.01 P/Share
|
Jun 05
2022
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+18.05%
|
-
|
Jun 05
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+18.0%
|
-
|
Jun 02
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
2,556
-2.25%
|
$10,224
$4.69 P/Share
|
Jun 02
2022
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,135
-0.96%
|
$8,540
$4.69 P/Share
|
Jun 02
2022
|
Dennis Weaver Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
1,548
-7.92%
|
$6,192
$4.69 P/Share
|
Jun 02
2022
|
Victoria Baltrus Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,222
-29.66%
|
$4,888
$4.69 P/Share
|
Jun 02
2022
|
Ranmali Bopitiya EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,961
-29.19%
|
$23,844
$4.69 P/Share
|
Jun 01
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,016
+5.82%
|
-
|
Jun 01
2022
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,016
+3.04%
|
-
|
Jun 01
2022
|
Dennis Weaver Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,171
+14.56%
|
-
|
Jun 01
2022
|
Victoria Baltrus Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,120
+50.0%
|
-
|
Jun 01
2022
|
Ranmali Bopitiya EVP & Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,424
+50.0%
|
-
|
Mar 10
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
11,638
-9.84%
|
$93,104
$8.3 P/Share
|
Mar 09
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+20.9%
|
-
|
Mar 08
2022
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
19,204
-8.15%
|
$134,428
$7.33 P/Share
|
Mar 07
2022
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+20.96%
|
-
|
Mar 02
2022
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,605
-1.48%
|
$15,630
$6.91 P/Share
|
Mar 02
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
2,680
-2.99%
|
$16,080
$6.92 P/Share
|
Mar 02
2022
|
Meghan V. Joyce Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,540
-5.57%
|
$15,240
$6.91 P/Share
|
Mar 02
2022
|
Dennis Weaver Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
1,890
-12.39%
|
$11,340
$6.94 P/Share
|
Mar 01
2022
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,016
+3.84%
|
-
|
Mar 01
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,016
+7.26%
|
-
|
Mar 01
2022
|
Meghan V. Joyce Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,016
+13.33%
|
-
|
Mar 01
2022
|
Dennis Weaver Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,171
+18.38%
|
-
|
Feb 16
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
49,355
-37.39%
|
$345,485
$7.18 P/Share
|
Feb 15
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
132,015
+27.52%
|
-
|
Dec 07
2021
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
86,160
-33.8%
|
-
|
Dec 05
2021
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+49.51%
|
-
|
Dec 02
2021
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,090
-29.79%
|
$16,720
$8.81 P/Share
|
Dec 02
2021
|
Meghan V. Joyce Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,090
-7.41%
|
$24,720
$8.75 P/Share
|
Dec 02
2021
|
Dennis Weaver Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
2,410
-20.97%
|
$19,280
$8.79 P/Share
|
Dec 01
2021
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,015
+50.0%
|
-
|